Actelion AC 058B302: Multicenter, randomized, double-blind, parallel-group, add-on, superiority study to compare the efficacy and safety of ponesimod to placebo in subjects with active relapsing multiple sclerosis who are treated with dimethyl fumarate (Tecfidera)

July 26, 2018
https://clinicaltrials.gov/ct2/show/NCT02907177
Multiple Sclerosis
Principal Investigator: Mirela Cerghet, MD
MS, Multiple Sclerosis, RMS, Relapsing Multiple Sclerosis
Accepting Participants